American International Group’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,015
| Closed | -$105K | – | 3250 |
|
|
2022
Q1 | $105K | Sell |
12,015
-845
| -7% | -$7.39K | ﹤0.01% | 2576 |
|
|
2021
Q4 | $206K | Sell |
12,860
-385
| -3% | -$6.17K | ﹤0.01% | 2352 |
|
|
2021
Q3 | $244K | Sell |
13,245
-314
| -2% | -$5.79K | ﹤0.01% | 2309 |
|
|
2021
Q2 | $189 | Buy |
13,559
+1,643
| +14% | +$23 | ﹤0.01% | 2540 |
|
|
2021
Q1 | $175 | Buy |
11,916
+31
| +0.3% | – | ﹤0.01% | 2435 |
|
|
2020
Q4 | $230 | Buy |
11,885
+3,045
| +34% | +$59 | ﹤0.01% | 2205 |
|
|
2020
Q3 | $99K | Buy |
8,840
+38
| +0.4% | +$426 | ﹤0.01% | 2547 |
|
|
2020
Q2 | $119K | Buy |
8,802
+1,176
| +15% | +$15.9K | ﹤0.01% | 2419 |
|
|
2020
Q1 | $62K | Buy |
7,626
+623
| +9% | +$5.07K | ﹤0.01% | 2577 |
|
|
2019
Q4 | $67K | Buy |
7,003
+115
| +2% | +$1.1K | ﹤0.01% | 2807 |
|
|
2019
Q3 | $73K | Buy |
6,888
+374
| +6% | +$3.96K | ﹤0.01% | 2759 |
|
|
2019
Q2 | $75K | Buy |
6,514
+1,430
| +28% | +$16.5K | ﹤0.01% | 2822 |
|
|
2019
Q1 | $65K | Sell |
5,084
-464
| -8% | -$5.93K | ﹤0.01% | 2789 |
|
|
2018
Q4 | $34K | Sell |
5,548
-43
| -0.8% | -$264 | ﹤0.01% | 2965 |
|
|
2018
Q3 | $59K | Buy |
5,591
+1,246
| +29% | +$13.1K | ﹤0.01% | 3032 |
|
|
2018
Q2 | $64K | Buy |
4,345
+488
| +13% | +$7.19K | ﹤0.01% | 2939 |
|
|
2018
Q1 | $55K | Sell |
3,857
-206
| -5% | -$2.94K | ﹤0.01% | 2881 |
|
|
2017
Q4 | $48K | Buy |
+4,063
| New | +$48K | ﹤0.01% | 2951 |
|